Management Alert: EXIM Has Not Fully Complied with Antideficiency Act Reporting Requirements

Submitting OIG:

Date Issued:

Friday, September 29, 2023

Agency Reviewed / Investigated:

Submitting OIG-Specific Report Number:

OIG-O-23-04

Location(s):

Agency-Wide

Type of Report:

Other

Questioned Costs:

Funds for Better Use:

Number of Recommendations:

Report updated under NDAA 5274:

View Document:

Attachment	Size
EXIM-OIG-Management-Alert-OIG-O-23-04FINAL.pdf	1.7 MB

Related Open Recommendations

Recommendation Number	Recommendation Status	Significant Recommendation
1	Open	No
Coordinate with OMB, and if necessary, obtain clearance for EXIM to immediately report the 2019 Antideficiency Act violation the agency identified, consistent with 31 U.S.C. § 1517(b) and the requirements of OMB Circular A-11.
2	Open	No
If applicable, and after obtaining clearance from OMB, EXIM’s President and Chair should immediately report the 2019 Antideficiency Act violation the agency identified to the President, Congress, and the Comptroller General, consistent with 31 U.S.C. § 1517(b).
3	Open	No
Formally document EXIM’s internal processes for maintaining records and reporting future Antideficiency Act violations to all required parties in a timely manner.